PLx Pharma Winddown Corp.

2018 Q4 Form 10-K Financial Statement

#000143774919004386 Filed on March 08, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 2017 Q4

Balance Sheet

Concept 2018 Q4 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.25M $14.25M $24.40M
YoY Change -41.6% -41.6% 40566.67%
Cash & Equivalents $14.25M $14.25M $24.40M
Short-Term Investments
Other Short-Term Assets $600.0K $600.0K $1.020M
YoY Change -41.18% -41.18%
Inventory $0.00 $0.00 $246.4K
Prepaid Expenses $409.4K $300.2K
Receivables $20.00K $20.00K $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.87M $14.87M $25.69M
YoY Change -42.14% -42.12% 13431.43%
LONG-TERM ASSETS
Property, Plant & Equipment $1.394M $1.390M $1.030M
YoY Change 35.38% 34.95% 141.4%
Goodwill $2.061M $2.061M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.00K $70.00K $70.00K
YoY Change 0.0% 0.0% 23.61%
Total Long-Term Assets $3.523M $3.520M $3.159M
YoY Change 11.54% 11.39% 640.36%
TOTAL ASSETS
Total Short-Term Assets $14.87M $14.87M $25.69M
Total Long-Term Assets $3.523M $3.520M $3.159M
Total Assets $18.39M $18.39M $28.85M
YoY Change -36.26% -36.26% 4579.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $650.0K $650.0K $850.0K
YoY Change -23.53% -23.53% -1.16%
Accrued Expenses $1.170M $1.170M $960.0K
YoY Change 21.88% 21.88% 860.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $2.910M $2.910M
YoY Change
Total Short-Term Liabilities $4.733M $4.730M $1.816M
YoY Change 160.65% 159.89% -33.63%
LONG-TERM LIABILITIES
Long-Term Debt $4.280M $4.280M $6.942M
YoY Change -38.34% -38.33%
Other Long-Term Liabilities $84.28K $2.930M $141.7K
YoY Change -40.52% -81.06%
Total Long-Term Liabilities $4.365M $7.210M $7.084M
YoY Change -38.39% -67.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.733M $4.730M $1.816M
Total Long-Term Liabilities $4.365M $7.210M $7.084M
Total Liabilities $11.94M $11.94M $24.23M
YoY Change -50.71% -50.72% 725.4%
SHAREHOLDERS EQUITY
Retained Earnings -$66.44M -$67.33M
YoY Change -1.33% 29.52%
Common Stock $72.88M $71.95M
YoY Change 1.29% 44.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.444M $6.440M $4.616M
YoY Change
Total Liabilities & Shareholders Equity $18.39M $18.39M $28.85M
YoY Change -36.26% -36.26% 4579.5%

Cashflow Statement

Concept 2018 Q4 2018 2017 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8750606
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2017 plxp Effective Income Tax Rate Reconciliation Fair Value Of Derivatives Percent
EffectiveIncomeTaxRateReconciliationFairValueOfDerivativesPercent
0.014
CY2018 plxp Effective Income Tax Rate Reconciliation Release Of Valuation Allowance Related To A Merger Percent
EffectiveIncomeTaxRateReconciliationReleaseOfValuationAllowanceRelatedToAMergerPercent
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018Q2 dei Entity Public Float
EntityPublicFloat
34053848
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
1048393
CY2017Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
849703
CY2018 plxp Amortization Of Deferred Financing Fees
AmortizationOfDeferredFinancingFees
247943
CY2017 plxp Amortization Of Deferred Financing Fees
AmortizationOfDeferredFinancingFees
724676
CY2018Q4 plxp Contract Manufacturing Deposits Current
ContractManufacturingDepositsCurrent
12564
CY2017Q4 plxp Contract Manufacturing Deposits Current
ContractManufacturingDepositsCurrent
719667
CY2018Q4 plxp Deferred Tax Assets And Liabilities Net
DeferredTaxAssetsAndLiabilitiesNet
17823568
CY2017Q4 plxp Deferred Tax Assets And Liabilities Net
DeferredTaxAssetsAndLiabilitiesNet
16132033
CY2018 plxp Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate And Other Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRateAndOtherPercent
-1.887
CY2017 plxp Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate And Other Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRateAndOtherPercent
0.0244
CY2018 plxp Effective Income Tax Rate Reconciliation Fair Value Of Derivatives Percent
EffectiveIncomeTaxRateReconciliationFairValueOfDerivativesPercent
3.48
CY2017 plxp Effective Income Tax Rate Reconciliation Release Of Valuation Allowance Related To A Merger Percent
EffectiveIncomeTaxRateReconciliationReleaseOfValuationAllowanceRelatedToAMergerPercent
-0.0599
CY2018 plxp Equity Offering Proceeds Allocated To Warrant Liability
EquityOfferingProceedsAllocatedToWarrantLiability
CY2017 plxp Equity Offering Proceeds Allocated To Warrant Liability
EquityOfferingProceedsAllocatedToWarrantLiability
15876546
CY2018 plxp Expenses Allocated To Warrant Liability
ExpensesAllocatedToWarrantLiability
CY2017 plxp Expenses Allocated To Warrant Liability
ExpensesAllocatedToWarrantLiability
1302995
CY2018 plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
198690
CY2017 plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-1434297
CY2018 plxp Increase Decrease In Contract Manufacturing Deposits
IncreaseDecreaseInContractManufacturingDeposits
-707103
CY2017 plxp Increase Decrease In Contract Manufacturing Deposits
IncreaseDecreaseInContractManufacturingDeposits
715603
CY2018 plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
225870
CY2017 plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
229845
CY2018 plxp Increase Decrease In Interest Payable To Related Parties Net
IncreaseDecreaseInInterestPayableToRelatedPartiesNet
CY2017 plxp Increase Decrease In Interest Payable To Related Parties Net
IncreaseDecreaseInInterestPayableToRelatedPartiesNet
13747
CY2018Q4 plxp Intangible Assets Accumulated Impairments
IntangibleAssetsAccumulatedImpairments
CY2017Q4 plxp Intangible Assets Accumulated Impairments
IntangibleAssetsAccumulatedImpairments
2294048
CY2018Q4 plxp Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
2061022
CY2017Q4 plxp Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
4361022
CY2018Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
309440
CY2017Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
89717
CY2018Q4 plxp Operating Leases Future Minimum Payments Receivable Due
OperatingLeasesFutureMinimumPaymentsReceivableDue
287724
CY2018Q4 plxp Operating Leases Future Minimum Payments Receivable Due Current
OperatingLeasesFutureMinimumPaymentsReceivableDueCurrent
139427
CY2018Q4 plxp Operating Leases Future Minimum Payments Receivable Due In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableDueInThreeYears
61941
CY2018Q4 plxp Operating Leases Future Minimum Payments Receivable Due In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableDueInTwoYears
86356
CY2018 plxp Operating Loss Carryforwards Beginning Expiration Year
OperatingLossCarryforwardsBeginningExpirationYear
2035
CY2018 plxp Proceeds From Convertible Debt Excluding Related Parties
ProceedsFromConvertibleDebtExcludingRelatedParties
CY2017 plxp Proceeds From Convertible Debt Excluding Related Parties
ProceedsFromConvertibleDebtExcludingRelatedParties
460000
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
588300
CY2018 plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
CY2017 plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
108300
CY2018 plxp Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs
ProceedsFromIssuanceOfTermLoanAndWarrantsNetOfAllocatedIssuanceCosts
CY2017 plxp Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs
ProceedsFromIssuanceOfTermLoanAndWarrantsNetOfAllocatedIssuanceCosts
7145584
CY2018 plxp Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfAllocatedIssuanceCosts
CY2017 plxp Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfAllocatedIssuanceCosts
16698854
CY2017 plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued In Connection With Merger
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedInConnectionWithMerger
191963
CY2017 plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued In Connection With Merger Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedInConnectionWithMergerWeightedAverageExercisePrice
57.94
CY2018 plxp Term Loan Proceeds Allocated To Warrants
TermLoanProceedsAllocatedToWarrants
CY2017 plxp Term Loan Proceeds Allocated To Warrants
TermLoanProceedsAllocatedToWarrants
304201
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
653049
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
852155
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
292080
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91123
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
72871317
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
71939917
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
304201
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
841421
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1624411
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3911302
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3871302
CY2017Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2294048
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q4 us-gaap Assets
Assets
18388376
CY2017Q4 us-gaap Assets
Assets
28848573
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14865410
CY2017Q4 us-gaap Assets Current
AssetsCurrent
25689962
CY2018 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
CY2017 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
15048883
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
89558
CY2018 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2017 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11776427
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14250267
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24404368
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59335
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10154101
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
24345033
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
14300000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8738163
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8722823
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8738163
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8722823
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
8744
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
8723
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2018 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
CY2017 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2495630
CY2018 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
174976
CY2017 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2018Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
174976
CY2017Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1446640
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
12770584
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-920000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
305619
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8922
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
244896
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
451556
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
372944
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18129187
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16140955
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11745648
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8715591
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
373314
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
350690
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1790387
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3616246
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3768282
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3085484
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17823568
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16132033
CY2017Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
920000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
305619
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8922
CY2018Q4 us-gaap Deposit Assets
DepositAssets
8500
CY2017Q4 us-gaap Deposit Assets
DepositAssets
715603
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
67714
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
67714
CY2018 us-gaap Depreciation
Depreciation
200957
CY2017 us-gaap Depreciation
Depreciation
29838
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200957
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29838
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2537317
CY2017Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
15242915
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.19
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.19
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.036
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y328D
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
553416
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12705598
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.06
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.378
CY2018 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-1.347
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-633631
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5952
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
100000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
524245
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7791600
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10174997
CY2018Q4 us-gaap Goodwill
Goodwill
2061022
CY2017Q4 us-gaap Goodwill
Goodwill
2061022
CY2017Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2018 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2017 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2294048
CY2017Q4 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2300000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
896480
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16266731
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-920000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q1 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-5900000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-194524
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-109644
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1150
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14307
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-200000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-10961157
CY2017Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
2061022
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
1145761
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
223583
CY2018Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2200000
CY2018Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
2061022
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
1164897
CY2018 us-gaap Interest Paid Net
InterestPaidNet
671146
CY2017 us-gaap Interest Paid Net
InterestPaidNet
195938
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
60366
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
54219
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-15847842
CY2018Q4 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
246374
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
449384
CY2018 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-55897
CY2017 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
201321
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
109200
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1003000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
320000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
770619
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
319736
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
297800
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
112377
CY2018Q4 us-gaap Liabilities
Liabilities
11944083
CY2017Q4 us-gaap Liabilities
Liabilities
24232181
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18388376
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28848573
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4732660
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1815691
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2909709
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4280385
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6942151
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26412738
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-654870
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11238858
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9499231
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13306563
CY2018 us-gaap Net Income Loss
NetIncomeLoss
896480
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15346731
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11857637
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-418889
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2018 us-gaap Operating Expenses
OperatingExpenses
11714265
CY2017 us-gaap Operating Expenses
OperatingExpenses
16626499
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
842671
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
349804
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
190874
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
301993
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
554947
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
210377
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
128933
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
215637
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2346000
CY2017Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
18200000
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1686310
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1120998
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
114460
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
175552
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
54100000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61143
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
59614
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
84281
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
141707
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
654870
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
537569
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
409369
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
300169
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1394230
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1029875
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
18234
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
19384
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3922665
CY2018 us-gaap Revenues
Revenues
753108
CY2017 us-gaap Revenues
Revenues
778657
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4157454
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66435768
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67332248
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.55
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
841421
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1624411
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1028209
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.14
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
45000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
283372
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
85000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
90097
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
691374
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1166709
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1206709
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.44
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.54
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.93
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.75
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.46
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y222D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y226D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y306D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y354D
CY2018 us-gaap Stock Issued1
StockIssued1
90000
CY2017 us-gaap Stock Issued1
StockIssued1
60119
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15048883
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3119538
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60119
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2125303
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1624411
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
841421
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6444293
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4616392
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-2319332
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt Infinity%;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt Infinity%;text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, determining the fair value of tangible and intangible assets and liabilities acquired in business combinations, the fair value of warrant liabilities, stock-based compensation, allowance for inventory obsolescence, allowance for doubtful accounts, contingent liabilities, the fair value and depreciable lives of long-lived tangible and intangible assets, and deferred taxes and the associated valuation allowance. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1691536
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13690584
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8733220
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7020479
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8733220
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7020479

Files In Submission

Name View Source Status
0001437749-19-004386-index-headers.html Edgar Link pending
0001437749-19-004386-index.html Edgar Link pending
0001437749-19-004386.txt Edgar Link pending
0001437749-19-004386-xbrl.zip Edgar Link pending
ex_135616.htm Edgar Link pending
ex_135617.htm Edgar Link pending
ex_135618.htm Edgar Link pending
ex_135619.htm Edgar Link pending
ex_135620.htm Edgar Link pending
ex_135823.htm Edgar Link pending
ex_136977.htm Edgar Link pending
ex_136978.htm Edgar Link pending
ex_136979.htm Edgar Link pending
ex_136980.htm Edgar Link pending
ex_136981.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
heart.jpg Edgar Link pending
plxp-20181231.xml Edgar Link completed
plxp-20181231.xsd Edgar Link pending
plxp-20181231_cal.xml Edgar Link unprocessable
plxp-20181231_def.xml Edgar Link unprocessable
plxp-20181231_lab.xml Edgar Link unprocessable
plxp-20181231_pre.xml Edgar Link unprocessable
plxp20181231_10k.htm Edgar Link pending
plxp20181231_10kimg001.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending